Enovix (NASDAQ:ENVX – Get Free Report) is expected to be posting its quarterly earnings results after the market closes on Tuesday, February 18th. Analysts expect Enovix to post earnings of ($0.19) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Enovix Stock Up 0.1 %
ENVX stock opened at $11.79 on Tuesday. The firm’s 50-day moving average is $10.86 and its two-hundred day moving average is $10.39. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of -7.32 and a beta of 1.87. Enovix has a 52 week low of $5.70 and a 52 week high of $18.68.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the company. Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price target on shares of Enovix in a research report on Wednesday, October 30th. Benchmark reissued a “buy” rating and issued a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $20.50.
Insiders Place Their Bets
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the sale, the director now directly owns 99,497 shares of the company’s stock, valued at $968,105.81. The trade was a 42.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 15.70% of the company’s stock.
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- How to Invest in Blue Chip Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Using the MarketBeat Dividend Yield Calculator
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is a Special Dividend?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.